eFFECTOR Therapeutics, Inc. Operating Income
eFFECTOR Therapeutics, Inc. reported Operating Income of -$8.40 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2024-05-09
- eFFECTOR Therapeutics, Inc. operating income (loss) for the quarter ending 2024-03-31 was -$8.40M.
- eFFECTOR Therapeutics, Inc. operating income (loss) for the quarter ending 2023-12-31 was -$8.60M.
- eFFECTOR Therapeutics, Inc. operating income (loss) for the quarter ending 2023-09-30 was -$7.86M.
- eFFECTOR Therapeutics, Inc. operating income (loss) for the quarter ending 2023-06-30 was -$7.86M.
- eFFECTOR Therapeutics, Inc. operating income (loss) for fiscal 2023 was -$33.84M.
- eFFECTOR Therapeutics, Inc. operating income (loss) for fiscal 2022 was -$32.40M.
- eFFECTOR Therapeutics, Inc. operating income (loss) for fiscal 2021 was -$31.90M, a 301.64% decline from fiscal 2020.
- eFFECTOR Therapeutics, Inc. operating income (loss) for fiscal 2020 was $15.82M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|
| 2024-03-31 | -$8.40M 10-Q · filed 2024-05-09 | -$16.99M derived: sum of 2 quarters · filed 2024-05-09 | -$24.85M derived: sum of 3 quarters · filed 2024-05-09 | -$32.70M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2023-12-31 | -$8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$16.45M derived: sum of 2 quarters · filed 2024-03-26 | -$24.31M derived: sum of 3 quarters · filed 2024-03-26 | -$33.84M 10-K · filed 2024-03-26 | ||
| 2023-09-30 | -$7.86M 10-Q · filed 2023-11-13 | -$15.71M derived: sum of 2 quarters · filed 2023-11-13 | -$25.25M 10-Q · filed 2023-11-13 | -$33.97M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2023-06-30 | -$7.86M 10-Q · filed 2023-08-08 | -$17.39M 10-Q · filed 2023-08-08 | -$26.11M derived: sum of 3 quarters · filed 2024-05-09 | -$35.37M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2023-03-31 | -$9.54M 10-Q · filed 2024-05-09 | -$18.26M derived: sum of 2 quarters · filed 2024-05-09 | -$27.51M derived: sum of 3 quarters · filed 2024-05-09 | -$35.39M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | -$8.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$17.97M derived: sum of 2 quarters · filed 2024-03-26 | -$25.86M derived: sum of 3 quarters · filed 2024-03-26 | -$32.40M 10-K · filed 2024-03-26 | ||
| 2022-09-30 | -$9.25M 10-Q · filed 2023-11-13 | -$17.13M derived: sum of 2 quarters · filed 2023-11-13 | -$23.68M 10-Q · filed 2023-11-13 | -$36.08M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | -$7.88M 10-Q · filed 2023-08-08 | -$14.43M 10-Q · filed 2023-08-08 | -$26.83M derived: sum of 3 quarters · filed 2023-08-08 | -$35.55M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | -$6.55M 10-Q · filed 2023-05-09 | -$18.95M derived: sum of 2 quarters · filed 2023-05-09 | -$27.66M derived: sum of 3 quarters · filed 2023-05-09 | -$32.71M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | -$12.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$21.12M derived: sum of 2 quarters · filed 2023-03-08 | -$26.16M derived: sum of 3 quarters · filed 2023-03-08 | -$31.90M 10-K · filed 2023-03-08 | ||
| 2021-09-30 | -$8.71M 10-Q · filed 2022-11-07 | -$13.76M derived: sum of 2 quarters · filed 2022-11-07 | -$19.50M 10-Q · filed 2022-11-07 | -$25.11M derived: sum of 4 quarters · filed 2022-11-07 | ||
| 2021-06-30 | -$5.04M 10-Q · filed 2022-08-09 | -$2.24M 10-Q · filed 2021-08-12 | -$10.78M 10-Q · filed 2022-08-09 | -$2.61M 10-Q · filed 2021-08-12 | -$16.40M derived: sum of 3 quarters · filed 2022-08-09 | -$23.67M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$5.74M 10-Q · filed 2022-05-10 | -$368.77K 10-Q · filed 2021-06-03 | -$11.36M derived: sum of 2 quarters · filed 2022-05-10 | -$18.63M derived: sum of 3 quarters · filed 2022-05-10 | -$9.52M derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$5.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | -$12.89M derived: sum of 2 quarters · filed 2022-03-16 | -$3.79M derived: sum of 3 quarters · filed 2022-03-16 | $15.82M 10-K · filed 2022-03-16 | ||
| 2020-09-30 | -$7.27M 10-Q · filed 2021-11-08 | $1.83M derived: sum of 2 quarters · filed 2021-11-08 | $21.44M 10-Q · filed 2021-11-08 | |||
| 2020-06-30 | $9.10M 8-K · filed 2021-08-31 | $28.71M 8-K · filed 2021-08-31 |